Premier Alternatives

CytoRecovery

Blacksburg, VA · Founded 2017 · Privately Held (backing)

Developer of microfluidic technology designed to recover biological cells from samples. CytoRecovery is based in Blacksburg, VA and was founded in 2017. It was valued at $11 million at its later-stage round in Oct 2023, the last priced event on record. It has raised $11.2 million across 3 recorded rounds; the latest was a $2.1 million seed round in Jul 2022.

PMV mark · valuation
$11.0M
Oct 2026
Priced at
its later-stage round
Oct 2023
Total raised
$11.2M
Last round
Seed Round
Jul 2022

CytoRecovery key facts

as of Oct 2026
  • Developer of microfluidic technology designed to recover biological cells from samples.
  • CytoRecovery is valued at approximately $11.0M as of Oct 2026, set at its later-stage round, Oct 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $11.2M across 3 recorded rounds; the latest was Seed Round ($2.1M) in Jul 2022.
  • Notable investors include US National Science Foundation, MedTech Innovator, Keiretsu Forum, Virginia Innovation Partnership Corporation, Virginia Venture Partners — 15 tracked in total.
  • CytoRecovery has filed 5 Form Ds with the SEC since 2019, most recently Jul 2022 ($2.1M sold to 24 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$11.0M

Valued at $11.0M at its later-stage round, Oct 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of CytoRecovery with a free account
  • ·The complete investor list: 15 names
  • ·Watch CytoRecovery: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CytoRecovery funding rounds

3 rounds
Jul 2022Seed Round$2.1MSEC filing▮
Apr 2019Debt$1.3MSEC filing▮
May 2018Debt$500KSEC filing▮
Full funding history →

CytoRecovery valuation

CytoRecovery was valued at $11 million at its later-stage round in Oct 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has CytoRecovery raised?

CytoRecovery has raised $11.2 million in total; 3 of its rounds are on record, from 2018 on. The largest on record was a $500,000 debt round in May 2018; the most recent was a $2.1 million seed round in Jul 2022.

CytoRecovery has filed 5 Form Ds with the SEC since 2019, most recently in Jul 2022 ($2.1 million sold to 24 investors).

CytoRecovery investors

15 investors are on record for CytoRecovery, including US National Science Foundation, MedTech Innovator, Keiretsu Forum and Virginia Innovation Partnership Corporation. The seed round in Jul 2022 drew 24 investors.

About CytoRecovery

Developer of microfluidic technology designed to recover biological cells from samples. The company's technology offers cell biology analytics, individual trapping, and release of rare cell populations for downstream analysis, enabling biologists to select and separate rare, homogeneous, viable cell subpopulations from tissue, blood, and other biological samples.

Sector
Healthcare
HQ
Blacksburg, VA, United States
Founded
2017
Employees
7
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.